DK0651648T3 - Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom - Google Patents

Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom

Info

Publication number
DK0651648T3
DK0651648T3 DK93915854T DK93915854T DK0651648T3 DK 0651648 T3 DK0651648 T3 DK 0651648T3 DK 93915854 T DK93915854 T DK 93915854T DK 93915854 T DK93915854 T DK 93915854T DK 0651648 T3 DK0651648 T3 DK 0651648T3
Authority
DK
Denmark
Prior art keywords
treatment
consumptive
pct
thrombo
pharmaceutical preparation
Prior art date
Application number
DK93915854T
Other languages
English (en)
Inventor
Jean-Claude Mestries
Francis Herodin
Serge Martin
Armaud Ythier
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929214489A external-priority patent/GB9214489D0/en
Priority claimed from GB939301251A external-priority patent/GB9301251D0/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0651648T3 publication Critical patent/DK0651648T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93915854T 1992-07-08 1993-07-08 Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom DK0651648T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929214489A GB9214489D0 (en) 1992-07-08 1992-07-08 Pharmaceutical compositions and uses therefor
GB939301251A GB9301251D0 (en) 1993-01-22 1993-01-22 Pharmaceutical compositions and use therefor
PCT/EP1993/001790 WO1994001123A1 (en) 1992-07-08 1993-07-08 Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder

Publications (1)

Publication Number Publication Date
DK0651648T3 true DK0651648T3 (da) 2003-01-06

Family

ID=26301225

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93915854T DK0651648T3 (da) 1992-07-08 1993-07-08 Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom

Country Status (13)

Country Link
US (1) US5925344A (da)
EP (1) EP0651648B1 (da)
JP (1) JP3845112B2 (da)
AT (1) ATE228848T1 (da)
AU (1) AU674864B2 (da)
CA (1) CA2139353C (da)
DE (1) DE69332541T2 (da)
DK (1) DK0651648T3 (da)
ES (1) ES2183814T3 (da)
IL (1) IL106272A (da)
MX (1) MX9304075A (da)
PT (1) PT651648E (da)
WO (1) WO1994001123A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108982B1 (en) 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
AU3704500A (en) * 1999-02-19 2001-01-22 University Of Iowa Research Foundation, The Diagnostics and therapeutics for arterial wall disruptive disorders
EP1066834A3 (de) * 1999-07-08 2004-06-02 Thomas Dr. Stief Pharmazeutische Zusammensetzungen enthaltend ein phagozytenmodulierendes Agens
CN1434703A (zh) * 2000-08-24 2003-08-06 利统股份有限公司 延迟释放组合物及组合
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
EP3150635A3 (en) * 2009-10-16 2017-06-21 Omeros Corporation Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation
US9644035B2 (en) 2011-04-08 2017-05-09 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
RU2477530C2 (ru) * 2011-04-28 2013-03-10 Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к интерлейкину-6

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
JPH0372429A (ja) * 1988-10-07 1991-03-27 Chugai Pharmaceut Co Ltd 血小板減少症の治療剤
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
US5087448A (en) * 1989-02-02 1992-02-11 The Board Of Regents Of The University Of Oklahoma Enhancing growth of megakaryocytes in mammals using interleuking 6
JPH04218000A (ja) * 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
US5188828A (en) * 1990-11-08 1993-02-23 Brigham And Women's Hospital Interleukin-6 to stimulate erythropoietin production
WO1992008483A1 (en) * 1990-11-13 1992-05-29 The Children's Medical Center Corporation CONTROLLING β-AMYLOID RELATED NEURONAL DEGENERATION BY ANTAGONIZING NGF-EFFECTED NEURONAL ACTIVITY
WO1993006840A1 (en) * 1991-10-09 1993-04-15 Toray Industries, Inc. Medicine for preventing and treating bleeding tendency

Also Published As

Publication number Publication date
JPH08502028A (ja) 1996-03-05
MX9304075A (es) 1994-04-29
AU674864B2 (en) 1997-01-16
AU4566493A (en) 1994-01-31
ES2183814T3 (es) 2003-04-01
WO1994001123A1 (en) 1994-01-20
JP3845112B2 (ja) 2006-11-15
US5925344A (en) 1999-07-20
CA2139353C (en) 2006-11-07
EP0651648B1 (en) 2002-12-04
DE69332541T2 (de) 2003-04-17
ATE228848T1 (de) 2002-12-15
PT651648E (pt) 2003-04-30
EP0651648A1 (en) 1995-05-10
IL106272A (en) 1999-01-26
CA2139353A1 (en) 1994-01-20
DE69332541D1 (de) 2003-01-16
IL106272A0 (en) 1993-11-15

Similar Documents

Publication Publication Date Title
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
SE9604793L (sv) Nya Kristallmodifikationer
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
EP0584222A4 (en) Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
ATE165007T1 (de) Stabile lyophilisierte pharmazeutische zubereitungen von g-csf
DE69400435D1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
FI934298A0 (fi) Kristallin tiagabine-hydrokloridmonohydrat, dess framstaellning och dess anvaendning
IL106272A0 (en) Pharmaceutical compositions comprising il-6
DE69232516D1 (de) Behandlung von neurologischen Zuständen durch eine Interleukin-i-inhibierende Verbindung
NO944214D0 (no) Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister
MX9401406A (es) Agentes receptores de adenosina selectivos para intensificar el conocimiento.
ES2108122T3 (es) Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
PT706395E (pt) Uso de ropivacaina na preparacao duma composicao farmaceutica com efeito analgesico e bloqueio motor minimo
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
NO20006699D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
SE9303068D0 (sv) New use
DK0648117T3 (da) Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser
SE9301831D0 (sv) Pharmaceutical compositions
DK0495226T3 (da) Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma
DE69927599D1 (de) Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ATE153859T1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder